Fresh Human Leukopak - Mozobil/Neupogen® Mobilized (Day 6 Collection,Full Bag)
Fresh Human Leukopak - Mozobil/Neupogen® Mobilized (Day 6 Collection,Full Bag)
Product Overview
Leukopaks are highly-enriched leukapheresis-derived products obtained from an IRB-approved collection facility. Leukopaks contain higher concentrations of mononuclear cells, B cells, T cells, stem/progenitor cells, dendritic cells, and other cell types as compared to standard venipuncture collection methods or buffy coat products. Healthy, consented donors undergo a medical screening evaluation and are administered 5 doses of 10ug/kg TBW of Neupogen (filgrastim) on each of 5 days and two 240ug/kg TBW doses of Mozobil (plerixafor) on days 4 and 5 per IRB approved protocols prior to Leukapheresis. Leukapheresis is performed on the day of the 5th filgrastim dose following plerixafor administration and the next day using the Spectra Optia® Apheresis System. MNC rich cells, enriched with CD34+ cells mobilized into peripheral blood, are continuously collected from 2-2.5 donor blood volumes with ACD-A as an anticoagulant. Approximately 120mL of autologous plasma is automatically collected directly into the cell pool following leukapheresis. A nominal, post quality sampling, calculated volume of 290mL in a sterile transfer bag constitutes this product . Cell counts and CD34 quantities will vary based on the donor's response to mobilization. The total nucleated cell count is determined using AO/PI from the combined pool and provided as information. Fresh Mobilized leukapheresis products typically contain up to 1 % CD34+ cells, 40% granulocytes, and 5 % hematocrit. Exact percentages will vary from donor to donor. Manufactured by AllCells® Additional shipping charges apply for fresh, human origin products
Request More InfoStorage and Content
- 1 bag
SDS, CoA, and Instructions
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.